NeuBase Therapeutics, Inc. Operating Lease, Liability, Current
NeuBase Therapeutics, Inc. had Operating Lease, Liability, Current of $500.82 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2023-11-09
- 2023-09-30: Operating Lease, Liability, Current $500.82K.
- 2023-06-30: Operating Lease, Liability, Current $490.06K.
- 2023-03-31: Operating Lease, Liability, Current $479.49K.
- 2022-12-31: Operating Lease, Liability, Current $469.12K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-09-30 | $500.82K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $490.06K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $479.49K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $469.12K 10-Q · filed 2023-11-09 |
| 2022-09-30 | $553.07K 10-QT · filed 2023-06-05 |
| 2022-06-30 | $560.25K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $548.01K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $429.51K 10-Q · filed 2022-02-11 |
| 2021-09-30 | $382.58K 10-K · filed 2022-12-21 |
| 2021-06-30 | $273.58K 10-Q · filed 2021-08-13 |
| 2020-09-30 | $0.00 10-K · filed 2021-12-23 |